Improving Exposure Therapy: Rationale and Design of an International Consortium.
| Title: | Improving Exposure Therapy: Rationale and Design of an International Consortium. |
|---|---|
| Authors: | Smits JAJ; Department of Psychology, The University of Texas at Austin, 1 University Station, Mail Code A8000, Austin, TX 78712, USA. Electronic address: smits@utexas.edu.; Abramowitz JS; Department of Psychology, The University of North Carolina at Chapel Hill, Campus Box 3270, Chapel Hill, NC 27599, USA.; Arch JJ; Department of Psychology and Neuroscience, University of Colorado Boulder, Boulder, CO, USA.; Papini S; Department of Psychology, University of Hawai'i at Mānoa, 2530 Dole Street, Sakamaki C400, Honolulu, HI 96822, USA.; Anderson RA; School of Population Health and enAble Institute, Curtin University, Bentley, Western Australia, 6102 Australia.; Dixon LJ; Department of Psychology, University of Mississippi, P.O. Box 1848, University, MS 38677, USA.; Graham BM; School of Psychology, UNSW Sydney, New South Wales 2052 Australia.; Hofmann SG; Department of Psychology, University of Marburg, Marburg 35032, Germany.; Hoyer J; Technische Universität Dresden, Germany.; Huppert JD; Department of Psychology, The Hebrew University of Jerusalem, Mt. Scopus, Jerusalem, 91905 Israel.; Jacquart J; Department of Psychology, The University of Arizona, 1503 E. University Boulevard, Tucson, AZ 85721, USA.; Johnson D; Department of Psychological & Brain Sciences, Texas A&M University, 4235 TAMU, College Station, TX 77843, USA.; McEvoy PM; Centre for Clinical Interventions, Perth, Western Australia 6000, Australia.; McKay D; Department of Psychology, Fordham University, 441 East Fordham Road, Bronx, NY 10458-5198, USA.; Newby J; School of Psychology, UNSW Sydney at the Black Dog Institute, Hospital Road, Randwick, New South Wales 2031, Australia.; Otto MW; Department of Psychological and Brain Sciences, Boston University, 64 Cummington Mall, Boston, MA 02215, USA.; Pittig A; Translational Psychotherapy, Institute of Psychology, University of Goettingen, Germany.; Rief W; Department of Psychology, University of Marburg, 35032 Marburg, Germany.; Rosenfield D; Department of Psychology, Southern Methodist University, 6425 Boaz Lane, Dallas TX 75205, USA.; Timpano KR; Department of Psychology, The University of Miami, 5665 Ponce de Leon Boulevard, Coral Gables, FL 33146, USA.; Wannemüller A; Mental Health Research and Treatment Center, Ruhr University Bochum, Massenbergstr. 9-13, Bochum 44787, Germany. |
| Corporate Authors: | Exposure Therapy Consortium |
| Source: | The Psychiatric clinics of North America [Psychiatr Clin North Am] 2024 Jun; Vol. 47 (2), pp. 433-444. Date of Electronic Publication: 2024 Mar 19. |
| Publication Type: | Journal Article; Review; Research Support, N.I.H., Extramural |
| Language: | English |
| Journal Info: | Publisher: W B Saunders Country of Publication: United States NLM ID: 7708110 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1558-3147 (Electronic) Linking ISSN: 0193953X NLM ISO Abbreviation: Psychiatr Clin North Am Subsets: MEDLINE |
| Imprint Name(s): | Publication: Philadelphia Pa : W B Saunders; Original Publication: Philadelphia, Saunders. |
| MeSH Terms: | Implosive Therapy*/methods; Stress Disorders, Post-Traumatic/therapy ; Humans |
| Abstract: | The Exposure Therapy Consortium (ETC) was established to advance the science and practice of exposure therapy. To encourage participation from researchers and clinicians, this article describes the organizational structure and activities of the ETC. Initial research working group experiences and a proof-of-principle study underscore the potential of team science and larger-scale collaborative research in this area. Clinical working groups have begun to identify opportunities to enhance access to helpful resources for implementing exposure therapy effectively. This article discusses directions for expanding the consortium's activities and its impact on a global scale.; (Copyright © 2024 Elsevier Inc. All rights reserved.) |
| Competing Interests: | Disclosure Funding Support: Author effort was supported as follows: Dr J.A.J. Smits (NIMHR01MH125951), Dr S.G. Hofmann (Alexander von Humboldt Foundation, Germany and Hessische Ministerium für Wissenschaft und Kunst), Dr J. Newby (NHMRC2008839), Australia, and Dr M.W. Otto (NIMH R01 MH125949), United States. These funding sources had no role in the content or the decision to publish this article.Dr J.A.J. Smits receives funding from National Institute on Drug Abuse (NIDA R01DA047933), United States, the National Cancer Institute (NCI R01CA273221), United States, and Department of Defense (TP220002), United States, and compensation and royalties from various publishers. Dr J.J. Arch receives current research funding from the National Institutes of Health, United States/National Institute of Nursing Research (R01NR018479). Dr S G. Hofmann receives financial support by the Alexander von Humboldt Foundation (as part of the Alexander von Humboldt Professur) and the Hessische Ministerium für Wissenschaft und Kunst (as part of the LOEWE Spitzenprofessur). He also receives compensation for his work as editor from SpringerNature and royalties and payments for his work from various publishers. Dr P.M. McEvoy receives compensation from The Guilford Press, Elsevier, Cambridge University Press, and McGraw-Hill Education. Dr J. Newby receives funding from the Australian National Medical Research Council, and the Medical Research Future Fund. Dr M.W. Otto receives compensation as an advisor to Big Health and receives grant support from National Institute of Mental Health, United States, NIDA, and Big Health. Dr D. Rosenfield reports funding from NIMH, NCI, National Center for Complementary and Integrative Health, United States, and the Patient-Centered Outcomes Research Institute, United States. He also receives compensation from several scientific journals and from Rosenfield Analytics. Dr W.Rief received honoraria from Boehringer Ingelheim for talks on Post Covid, and he receives royalties from book publications from different publishers. All other authors report no conflicts of interest. |
| References: | Am Psychol. 2018 Apr;73(3):269-285. (PMID: 29494172); Front Psychol. 2018 Aug 21;9:1534. (PMID: 30186206); Behav Res Ther. 2006 Jan;44(1):85-98. (PMID: 16301016); Curr Top Behav Neurosci. 2023;64:307-333. (PMID: 37563489); Clin Psychol Rev. 2016 Nov;49:67-78. (PMID: 27611632); J Investig Med. 2012 Jun;60(5):768-75. (PMID: 22525233); Int J Epidemiol. 2020 Jun 1;49(3):979-995. (PMID: 32087011); Behav Res Ther. 2020 Dec;135:103735. (PMID: 33038799); Elife. 2017 Mar 15;6:. (PMID: 28294944); Science. 2007 May 18;316(5827):1036-9. (PMID: 17431139); Depress Anxiety. 2018 Jun;35(6):502-514. (PMID: 29451967); Psychol Assess. 2007 Jun;19(2):176-88. (PMID: 17563199); Neurosci Biobehav Rev. 2017 Jun;77:247-285. (PMID: 28263758) |
| Grant Information: | R01 MH125949 United States MH NIMH NIH HHS; R01 DA047933 United States DA NIDA NIH HHS; R01 MH125951 United States MH NIMH NIH HHS; R01 CA273221 United States CA NCI NIH HHS; R01 NR018479 United States NR NINR NIH HHS |
| Contributed Indexing: | Keywords: Exposure therapy; Implementation; Mechanism of action; Moderators; Team science; Treatment |
| Entry Date(s): | Date Created: 20240509 Date Completed: 20240509 Latest Revision: 20250602 |
| Update Code: | 20260130 |
| PubMed Central ID: | PMC11082449 |
| DOI: | 10.1016/j.psc.2024.02.008 |
| PMID: | 38724129 |
| Database: | MEDLINE |
Journal Article; Review; Research Support, N.I.H., Extramural